Injury to the bladder and/or ureters is the cause of significant morbidity, and efforts to reduce these injuries are important. This debate presents arguments that both support, and refute, the value of routine cystoscopy at the time of benign hysterectomy. Proponents of routine cystoscopy state that injuries are more likely to be detected and repaired when cystoscopy is routinely performed. Dissenters counter that the available evidence does not support routine cystoscopy at the current rates of lower urinary tract injury, and the cystoscopy should be performed only when injury is suspected or when performing hysterectomy with concurrent procedures that increase the risk of lower urinary tract injury.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ajog.2018.04.020 | DOI Listing |
Cancer Rep (Hoboken)
December 2024
Department of Internal Medicine, Hospital St. Josef Braunau, Braunau am Inn, Austria.
Urology
November 2024
Department of Urology, Sakarya University, School of Medicine, Serdivan, Sakarya, Turkey.
J Urol
November 2024
Departamento de Urologia, Centro Hospitalar e Universitário São João, Porto, Portugal.
Purpose: Alternative, noninvasive, cost-effective methods to complement or serve as substitutes to current standard-of-care (SOC) procedures in NMIBC follow-up are needed. Uromonitor is a urine biomarker test detecting bladder cancer recurrence through the screening of , , and hotspot mutations. The aim of this study was to assess Uromonitor performance by comparing it with the current SOC methods.
View Article and Find Full Text PDFInt J Womens Health
November 2024
Department of Urology, Wujin People's Hospital, Changzhou Medical Center, Nanjing Medical University, Changzhou, Jiangsu, 213100, People's Republic of China.
Background: Intrauterine devices (IUDs) are among the most popular contraceptive methods globally due to their convenience and cost-effectiveness. However, improper placement can lead to complications such as device migration and uterine perforation, with increased risk observed when IUDs are implanted within four to six weeks postpartum. Typically, patients are asymptomatic or experience mild lower abdominal discomfort or minor abnormal vaginal bleeding following IUD displacement.
View Article and Find Full Text PDFActas Urol Esp (Engl Ed)
January 2025
Servicio de Urología, Hospital Universitario La Paz, Madrid, Spain.
Introduction: The Optilume® Paclitaxel-coated urethral dilatation balloon is an alternative to conventional endoscopic treatments that combines mechanical dilatation with local delivery of paclitaxel.
Objective: To describe the success rate and analyze the safety of the device in real clinical practice. To evaluate possible predictors of treatment failure.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!